Skip to main content

Favorable-Risk Prostate Cancer

Meaning

Favorable-Risk Prostate Cancer refers to a specific classification of prostate malignancy characterized by clinical parameters suggesting a low likelihood of aggressive progression, metastasis, or cancer-specific mortality over a period of many years. This clinical designation is typically assigned to patients with a low Prostate-Specific Antigen (PSA) level, a low Gleason score, and a low clinical tumor stage. Identifying this risk group is crucial in clinical practice as it guides treatment decisions, often favoring active surveillance over immediate, aggressive interventions like surgery or radiation. This approach minimizes the morbidity and potential side effects associated with definitive treatment in men who may never experience clinically significant disease progression.